Last week CDMO Rentschler Biopharma said it plans to ... "Thermo Fisher continues viral vector withdrawal; lays off 300 employees" was originally created and published by Pharmaceutical Technology ...

Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes ...

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy ...

ENCell inks an MOU with CRC to enhance collaboration in the field of cell and gene therapy (CGT), thus expanding its market ...

Companies operating in the pharmaceutical and biotech sectors must evaluate a range of critical factors prior to partnering with a contract development and manufacturing organization (CDMO).

That deal complements the CDMO’s mass spectrometry offerings ... plans to let go of altogether 460 workers at its viral vector manufacturing facilities in Lexington, Cambridge and Plainville ...

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the ...

Northern Ireland-based contract development and manufacturing organization (CDMO) Almac is continuing its expansion tear with the opening of a new 65 million pounds sterling ($83.7 million ...

Prior to joining Prolific, Perry spent the past four years with Forge Biologics, a viral vector gene therapy manufacturing and development company with the dual platform of CDMO capabilities and ...

BIOVECTRA is a part of Agilent, a leader in clinical and analytical lab technologies and specialized CDMO services. With operations in Atlantic Canada, BIOVECTRA specializes in clinical-to-commercial ...